Viewing Study NCT00388518


Ignite Creation Date: 2025-12-25 @ 4:48 AM
Ignite Modification Date: 2026-03-04 @ 11:10 PM
Study NCT ID: NCT00388518
Status: COMPLETED
Last Update Posted: 2016-11-02
First Post: 2006-10-16
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of Aleglitazar in Patients With Type 2 Diabetes
Sponsor: Hoffmann-La Roche
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module